A Safety Study of MM-121 With Cetuximab and Irinotecan in Patients With Advanced Cancers
Conditions
- Colorectal Cancer
- Squamous Cell Head and Neck Cancer
- Non-small Cell Lung Cancer
- Triple Negative Breast Cancer
- Other Tumors With EGFR Dependence
Interventions
- DRUG: MM-121
- DRUG: Irinotecan
- DRUG: Cetuximab
Sponsor
Merrimack Pharmaceuticals
Collaborators